相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Real-Time RT-PCR Analysis for Evaluating the Her2/neu Status in Breast Cancer
M. Cuadros et al.
PATHOBIOLOGY (2010)
Guidelines for Human Epidermal Growth Factor Receptor 2 Testing: Biologic and Methodologic Considerations
Guido Sauter et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Prediction of HER2 gene status in Her2 2+invasive breast cancer: a study of 108 cases comparing ASCO/CAP and FDA recommendations
Frederic Chibon et al.
MODERN PATHOLOGY (2009)
Polysomy 17 in Breast Cancer: Clinicopathologic Significance and Impact on HER-2 Testing
Isabelle Vanden Bempt et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
The effect of chromosome 17 polysomy on HER-2/neu status in breast cancer
C. L. Hyun et al.
JOURNAL OF CLINICAL PATHOLOGY (2008)
Assessment of a new Anti-HER2 monoclonal antibody, SV2-61γ:: A best concordance with HER2 FISH
Yuriko Kitano et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2007)
Municipal distribution of breast cancer mortality among women in Spain
Marina Pollan et al.
BMC CANCER (2007)
Descriptive analysis of estrogen receptor (ER)negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype - A population-based study from the California Cancer Registry
Katrina R. Bauer et al.
CANCER (2007)
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Analysis of aneusomy level and HER-2 gene copy number and their effect on amplification rate in breast cancer specimens read as 2+in immunohistochemical analysis
R. Merola et al.
EUROPEAN JOURNAL OF CANCER (2006)
Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors
V Guarneri et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Determination of HER2 gene amplification by fluorescence in situ hybridization and concordance with the clinical trials immunohistochemical assay in women with metastatic breast cancer evaluated for treatment with trastuzumab
N Dybdal et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
The influence of polysomy 17 on HER2 gene and protein expression in adenocarcinoma of the breast - A fluorescent in situ hybridization, immunohistochemical, and isotopic mRNA in situ hybridization study
E Downs-Kelly et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Hormone receptor status and HER2/neu overexpression determined by automated immunostainer on routinely fixed cytologic specimens from breast carcinoma: Correlation with histologic sections determinations and diagnostic pitfalls
T Moriki et al.
DIAGNOSTIC CYTOPATHOLOGY (2004)
Impact of polysomy 17 on HER-2/neu immunohistochemistry in breast carcinomas without HER-2/neu gene amplification
P Lal et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2003)
Molecular prognostic factors for breast cancer metastasis and survival
FJ Esteva et al.
SEMINARS IN RADIATION ONCOLOGY (2002)
Determination of HER2 gene amplification by chromogenic in situ hybridization (CISH) in archival breast carcinoma
JX Zhao et al.
MODERN PATHOLOGY (2002)
分享论文
